Peter M. Schlag

16.6k total citations · 4 hit papers
187 papers, 12.4k citations indexed

About

Peter M. Schlag is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter M. Schlag has authored 187 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 53 papers in Molecular Biology and 46 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter M. Schlag's work include Gastric Cancer Management and Outcomes (20 papers), Photoacoustic and Ultrasonic Imaging (19 papers) and RNA Interference and Gene Delivery (17 papers). Peter M. Schlag is often cited by papers focused on Gastric Cancer Management and Outcomes (20 papers), Photoacoustic and Ultrasonic Imaging (19 papers) and RNA Interference and Gene Delivery (17 papers). Peter M. Schlag collaborates with scholars based in Germany, United States and United Kingdom. Peter M. Schlag's co-authors include Ulrike Stein, K. T. Moesta, Wolfgang Walther, M. Hünerbein, Walter Birchmeier, Bernard Nordlinger, Wolf O. Bechstein, Eric Van Cutsem, Wolfgang Kemmner and John Primrose and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Peter M. Schlag

179 papers receiving 12.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

2008 1.4k citations Peter M. Schlag et al. profile →
Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver Tumors

2002 868 citations Peter M. Schlag et al. profile →
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

2013 853 citations Peter M. Schlag et al. profile →
Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954

2010 507 citations Peter M. Schlag et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter M. Schlag Germany	57	4.9k	3.8k	3.2k	2.9k	2.2k	187	12.4k
Kenneth K. Tanabe United States	58	4.4k 0.9×	3.2k 0.8×	1.9k 0.6×	2.0k 0.7×	2.9k 1.3×	236	11.6k
Jean‐Yves Scoazec France	73	7.8k 1.6×	4.2k 1.1×	4.3k 1.3×	3.0k 1.0×	2.7k 1.2×	507	19.0k
Albert C. Koong United States	74	6.2k 1.3×	5.4k 1.4×	2.7k 0.9×	4.6k 1.6×	1.2k 0.5×	379	18.3k
Donato Nitti Italy	61	5.9k 1.2×	3.3k 0.9×	4.2k 1.3×	3.3k 1.1×	1.1k 0.5×	326	13.7k
Thomas Seufferlein Germany	57	5.5k 1.1×	5.2k 1.4×	2.5k 0.8×	2.4k 0.8×	881 0.4×	413	13.9k
Inne H.M. Borel Rinkes Netherlands	52	3.1k 0.6×	1.7k 0.4×	3.6k 1.1×	2.2k 0.7×	1.1k 0.5×	277	9.4k
Alfred E. Chang United States	67	11.3k 2.3×	4.2k 1.1×	2.5k 0.8×	3.4k 1.2×	986 0.4×	295	20.9k
Jürgen Weitz Germany	68	11.2k 2.3×	2.9k 0.8×	6.9k 2.2×	4.2k 1.4×	2.5k 1.1×	511	19.0k
Gordon C. Jayson United Kingdom	56	4.1k 0.8×	4.7k 1.2×	2.2k 0.7×	2.1k 0.7×	500 0.2×	257	14.0k
Peter J.K. Kuppen Netherlands	60	5.4k 1.1×	3.6k 0.9×	1.3k 0.4×	1.7k 0.6×	528 0.2×	313	11.9k

Countries citing papers authored by Peter M. Schlag

Since Specialization

Citations

This map shows the geographic impact of Peter M. Schlag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Schlag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Schlag more than expected).

Fields of papers citing papers by Peter M. Schlag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. Schlag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Schlag. The network helps show where Peter M. Schlag may publish in the future.

Co-authorship network of co-authors of Peter M. Schlag

This figure shows the co-authorship network connecting the top 25 collaborators of Peter M. Schlag. A scholar is included among the top collaborators of Peter M. Schlag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter M. Schlag. Peter M. Schlag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schulz, Julia, Nancy Mah, Martin Neuenschwander, et al.. (2018). Loss-of-function uORF mutations in human malignancies. Scientific Reports. 8(1). 2395–2395. 46 indexed citations

Juneja, Manisha, Dennis Kobelt, Wolfgang Walther, et al.. (2017). Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1. PLoS Biology. 15(6). e2000784–e2000784. 71 indexed citations

Kobelt, Dennis, Jutta Aumann, Manuel Schmidt, et al.. (2014). Preclinical study on combined chemo‐ and nonviral gene therapy for sensitization of melanoma using a human TNF‐alpha expressing MIDGE DNA vector. Molecular Oncology. 8(3). 609–619. 11 indexed citations

Stein, Ulrike, et al.. (2011). Diagnostic and Prognostic Value of Metastasis Inducer S100A4 Transcripts in Plasma of Colon, Rectal, and Gastric Cancer Patients. Journal of Molecular Diagnostics. 13(2). 189–198. 40 indexed citations

Sack, Ulrike, Wolfgang Walther, Dominic A. Scudiero, et al.. (2011). S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells. Molecular Biology of the Cell. 22(18). 3344–3354. 98 indexed citations

Cahill, Ronan A., A. Bembenek, Wolfgang Schneider, et al.. (2009). Sentinel Node Biopsy for the Individualization of Surgical Strategy for Cure of Early-Stage Colon Cancer. Annals of Surgical Oncology. 16(8). 2170–2180. 43 indexed citations

Walther, Wolfgang, Robert Siegel, Dennis Kobelt, et al.. (2008). Novel Jet-Injection Technology for Nonviral Intratumoral Gene Transfer in Patients with Melanoma and Breast Cancer. Clinical Cancer Research. 14(22). 7545–7553. 39 indexed citations

Sauer, Rolf, et al.. (2008). Multimodale Therapie des Rektumkarzinoms. Onkologie. 31(5). 24–28. 1 indexed citations

Schlag, Peter M., Ulrike Stein, & Alexander M.M. Eggermont. (2007). Regional Cancer Therapy. Humana Press eBooks. 11 indexed citations

10.

Stein, Ulrike, Stephan Bergmann, George L. Scheffer, et al.. (2005). YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene. Oncogene. 24(22). 3606–3618. 50 indexed citations

11.

Grosenick, Dirk, K. T. Moesta, Heidrun Wabnitz, et al.. (2003). Time-domain optical mammography: initial clinical results on detection and characterization of breast tumors. Applied Optics. 42(16). 3170–3170. 157 indexed citations

12.

Walther, Wolfgang, Ulrike Stein, & Peter M. Schlag. (2002). Use of the human MDR1 promoter for heat‐inducible expression of therapeutic genes. International Journal of Cancer. 98(2). 291–296. 2 indexed citations

13.

Knösel, Thomas, Ulrike Stein, Holger Schwabe, et al.. (2002). Overexpression of c-erbB-2 protein correlates with chromosomal gain at the c-erbB-2 locus and patient survival in advanced colorectal carcinomas. Clinical & Experimental Metastasis. 19(5). 401–407. 14 indexed citations

14.

Walther, Wolfgang, Ulrike Stein, & Peter M. Schlag. (2001). Use of the human MDR1 promoter for heat‐inducible expression of therapeutic genes. International Journal of Cancer. 98(2). 291–296. 18 indexed citations

15.

Wiechen, Kai, Christine Sers, Alexander I. Agoulnik, et al.. (2001). Down-Regulation of Caveolin-1, a Candidate Tumor Suppressor Gene, in Sarcomas. American Journal Of Pathology. 158(3). 833–839. 148 indexed citations

16.

Seitz, Susanne, Jörg Fischer, Lope Estévéz‐Schwarz, et al.. (2001). Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters. The Journal of Pathology. 194(3). 318–326. 27 indexed citations

17.

Stein, Ulrike, Beate Rau, Peter Wust, Wolfgang Walther, & Peter M. Schlag. (1999). Hyperthermia for treatment of rectal cancer: Evaluation for induction of multidrug resistance gene (mdr1) expression. International Journal of Cancer. 80(1). 5–12. 14 indexed citations

18.

Kemmner, Wolfgang, et al.. (1997). Inhibition of Galβ1,4GlcNAc α2,6 sialyltransferase expression by antisense‐oligodeoxynucleotides. FEBS Letters. 409(3). 347–350. 11 indexed citations

19.

Fantini, Sergio, Maria Angela Franceschini, G. Gaida, et al.. (1996). Frequency‐domain optical mammography: Edge effect corrections. Medical Physics. 23(1). 149–157. 92 indexed citations

20.

Jandrig, Burkhard, Susanne Seitz, Manuela Rodrigues Müller, et al.. (1996). BRCA1 mutations in German breast-cancer families. International Journal of Cancer. 68(2). 188–192. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact